GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (XBRU:MITRA) » Definitions » Additional Paid-In Capital

Mithra Pharmaceuticals (XBRU:MITRA) Additional Paid-In Capital : €413.16 Mil(As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Additional Paid-In Capital?


Mithra Pharmaceuticals's quarterly additional paid-in capital increased from Jun. 2022 (€385.06 Mil) to Dec. 2022 (€408.65 Mil) and increased from Dec. 2022 (€408.65 Mil) to Jun. 2023 (€413.16 Mil).

Mithra Pharmaceuticals's annual additional paid-in capital increased from Dec. 2020 (€332.54 Mil) to Dec. 2021 (€340.77 Mil) and increased from Dec. 2021 (€340.77 Mil) to Dec. 2022 (€408.65 Mil).

Mithra Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for Mithra Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Additional Paid-In Capital Chart

Mithra Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 221.59 258.90 332.54 340.77 408.65

Mithra Pharmaceuticals Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 335.29 340.77 385.06 408.65 413.16

Mithra Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Mithra Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Mithra Pharmaceuticals (XBRU:MITRA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (XBRU:MITRA) » Definitions » Additional Paid-In Capital
Comparable Companies
NGM:SAMT B OSTO:NNH OSTO:SODER XSAT:SUSG OSTO:JLT OSTO:HAV B NGM:CF1PREFP2 OSTO:KENH NGM:TPGR OSTO:LAMM B ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
0R91:UK 1TM:Germany
Address
Rue Saint-Georges 5, Liege, BEL, 4000
Website
https://www.mithra.com
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (XBRU:MITRA) Headlines

No Headlines